Skip to main content
Kitazato Corporation logo

Kitazato Corporation — Investor Relations & Filings

Ticker · 368A ISIN · JP3237550003 T Manufacturing
Open in API
Filings indexed 9 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country JP Japan
Listing T 368A

About Kitazato Corporation

https://www.kitazato.co.jp/en/

Kitazato Corporation is a global company engaged in the research, development, and manufacturing of biotechnological medical devices and media for assisted reproductive technologies (ART). The company provides a comprehensive product portfolio of over 550 items that cover the entire in vitro fertilization (IVF) cycle. Its offerings include oocyte retrieval needles, micro pipettes, culture media and oils, embryo transfer (ET) and intrauterine insemination (IUI) catheters. Kitazato is particularly known for developing the Cryotop® Method, a pioneering vitrification system for the cryopreservation of oocytes and embryos that has been widely adopted in the field.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 19
2025-11-13 Japanese
半期報告書－第19期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Tokai Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, for the interim period ending September 30, 2025. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2025-11-13 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is extremely short (650 characters) and contains a structured header typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted under Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act, addressed to the Tokai Local Finance Bureau Chief. The content confirms that the annual securities report ('有価証券報告書') for the period ending March 31, 2025, is appropriately prepared according to financial instruments laws. This document is a certification or confirmation related to the annual filing, not the full Annual Report (10-K) itself, nor is it a standard Earnings Release (ER) or Interim Report (IR). Since it is a specific confirmation document related to the annual filing process, and it doesn't fit perfectly into the other specific categories like Audit Report (AR) or Proxy Statement (PSI), it is best classified as a general Regulatory Filing (RNS), as it is a mandatory regulatory confirmation document that doesn't match the primary definitions provided. FY 2025
2025-06-30 Japanese
有価証券報告書－第18期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard comprehensive annual financial report required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, management discussion and analysis, and corporate information for the fiscal year ending March 31, 2025. This corresponds to the '10-K' category in the provided schema. FY 2025
2025-06-30 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being filed because the resolutions from the Annual General Meeting (定時株主総会) held on June 27, 2025, have been decided. Section 2 details the resolutions, including the approval of surplus distribution (dividend) and the revision of director compensation. This structure—reporting the results of a shareholder meeting—is characteristic of an AGM Results report. In the provided definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) fits best as it covers 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Although the filing itself is a Japanese 'Timely Disclosure Report' (which might sometimes map to RNS), the *content* is purely the voting results of the AGM.
2025-06-27 Japanese
臨時報告書
Major Shareholding Notification Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report/Temporary Report) and is submitted to the '東海財務局長' (Director of the Tokai Local Finance Bureau). The filing reason explicitly states it is submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related regulations due to a change in a major shareholder ('主要株主に異動がありました'). The content details the change in voting rights percentage for the major shareholder, '井上 太綬'. This type of mandatory disclosure regarding changes in major shareholdings (crossing thresholds) corresponds to the Major Shareholding Notification category.
2025-06-25 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.